Understanding Cross-Country Differences In Health Status And Expenditures

Raquel Fonseca (), Francois Langot, Pierre-Carl Michaud and Thepthida Sopraseuth

Working Papers from HAL

Abstract: Using a general equilibrium heterogeneous agent model featuring health production, we quantifythe relative contribution of price distortions in the health market, TFP and other health risks inexplaining cross-country differences in health expenditure (as a share of GDP) and health status.Estimated parameters reveal a substantial price wedge that explains at most 20% of the differencein health spending (as a share of GDP) and 30% of the difference in health status between Europeand the U.S. We estimate a one percentage point negative impact on the life-time cost-of-living ofAmericans from higher prices due to inefficiencies.

Date: 2022-05-25
New Economics Papers: this item is included in nep-dge and nep-hea
Note: View the original document on HAL open archive server: https://cyu.hal.science/hal-03679009v1
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://cyu.hal.science/hal-03679009v1/document (application/pdf)

Related works:
Working Paper: Understanding Cross-Country Differences in Health Status and Expenditures (2020)
Working Paper: Understanding Cross-country Differences in Health Status and Expenditures (2020)
Working Paper: Understanding Cross-country Differences in Health Status and Expenditures (2020)
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:hal:wpaper:hal-03679009

Access Statistics for this paper

More papers in Working Papers from HAL
Bibliographic data for series maintained by CCSD ().